Yoshida, Eric M

Artículo	Publicación	Periodo
Fatal hepatitis C associated fibrosing cholestatic hepatitis as a complication of cyclophosphamide and corticosteroid treatment of active glomerulonephritis	Annals of Hepatology	2007 Num. 3
Hepatology Highlights	Annals of Hepatology	2008 Num. 4
Mycophenolate mofetil in liver transplant patients with calcineurin-inhibitor-induced renal impairment	Annals of Hepatology	2008 Num. 4
Surgical morbidity in severely obese liver transplant recipients - A single Canadian Centre Experience	Annals of Hepatology	2009 Num. 1
Hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial	Annals of Hepatology	2009 Num. 1
The use of sildenafil to treat portopulmonary hypertension prior to liver transplantation	Annals of Hepatology	2009 Num. 2
Hepatology Highlights	Annals of Hepatology	2009 Num. 4
Late acute celiac and hepatic artery thrombosis with portal vein thrombosis resulting in hepatic infarction 12 years post orthotopic liver transplantation	Annals of Hepatology	2009 Num. 4
First confirmed case of native polyomavirus BK nephropathy in a liver transplant recipient seven years post-transplanterferon a, ribavirin and telaprevir	Annals of Hepatology	2015 Num. 1
Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experience	Annals of Hepatology	2014 Num. 5
Antimitochondrial antibody serocoversion post-liver transplant during hepatitis C treatment with peginterferon α, ribavirin and telaprevir	Annals of Hepatology	2014 Num. 5
Hepatology highlights	Annals of Hepatology	2014 Num. 4
A phase 2 study of filibuvir in combination with pegylated IFN alfa and ribavirin for chronic HCV	Annals of Hepatology	2014 Num. 4
Hepatitis B in pregnancy: a concise review of neonatal vertical transmission and antiviral prophylaxis	Annals of Hepatology	2014 Num. 2
Hepatology highlights	Annals of Hepatology	2013 Num. 3
The Annals of Hepatology welcomes the Canadian Association for the Study of the Liver (CASL)	Annals of Hepatology	2013 Num. 4
Non-invasive assessment of liver fibrosis using ARFI with pathological correlation, a prospective study	Annals of Hepatology	2013 Num. 4
First successful treatment of post-liver transplant hepatitis C fibrosing cholestatic hepatitis with boceprevir, peginterferon and ribavirin in a pre-transplant null responder	Annals of Hepatology	2013 Num. 1
A Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection	Annals of Hepatology	2013 Num. 2
Hepatology Highlights	Annals of Hepatology	2012 Num. 3
Hepatology Highlights	Annals of Hepatology	2012 Num. 1
Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients	Annals of Hepatology	2012 Num. 1
Hepatology Highlights	Annals of Hepatology	2012 Num. 5
Primary hepatic neuroendocrine tumour requiring live donor liver transplantation: case report and concise review	Annals of Hepatology	2012 Num. 5
A review of drug interactions with boceprevir and telaprevir: implications for HIV and transplant patients	Annals of Hepatology	2012 Num. 2
Concordance of sustained virologic response at weeks 4, 12 and 24 post-treatment of hepatitis C in the era of new oral direct-acting antivirals: A concise review	Annals of Hepatology	2016 Num. 2
The role of hepatitis B immunoglobulin in hepatitis B related liver transplantation: Canadian Transplant Centre Position Paper	Annals of Hepatology	2011 Num. 4
Is pre-treatment liver biopsy necessary for all hepatitis C genotypes?	Annals of Hepatology	2011 Num. 3
Hepatology Highlights	Annals of Hepatology	2011 Num. 2
Treatment issues surrounding hepatitis C in renal transplantation: A review	Annals of Hepatology	2011 Num. 1
Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials	Annals of Hepatology	2016 Num. 3
Celebrating Fifteen Years of Annals of Hepatology Publication: The International, Open Access, Clinical Journal Devoted to Liver Diseases	Annals of Hepatology	2017 Num. 1
Lamivudine, Entecavir, or Tenofovir Treatment of Hepatitis B Infection: Effects on Calcium, Phosphate, FGF23 and Indicators of Bone Metabolism	Annals of Hepatology	2017 Num. 2
Interaction of Gender and Hepatitis C in Risk of Chronic Renal Failure After Liver Transplantation	Annals of Hepatology	2017 Num. 2
The Direct-Acting Antivirals for Hepatitis C Virus and the Risk for Hepatocellular Carcinoma	Annals of Hepatology	2017 Num. 3
Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant	Annals of Hepatology	2017 Num. 3
Transplanting Kidney Allografts from Hepatitis C Infected Donors into Hepatitis C Uninfected Recipients: Re-Thinking the Thinker Trial	Annals of Hepatology	2017 Num. 5
Annals of Hepatology: Viewpoints from Afar	Annals of Hepatology	2018 Num. 1
Sofosbuvir-Based Therapy in the Pre-Liver Transplant Setting: The Canadian National Experience	Annals of Hepatology	2018 Num. 3
Choosing Wisely Canada-Top Five List in Hepatology: Official Position Statement of the Canadian Association for the Study of the Liver (CASL) and Choosing Wisely Canada (CWC)	Annals of Hepatology	2019 Num. 1